
zzso is currently considered a global epidemic and its prevention and treatment is a major public health concern, demanding treatment which may combine a zzso approach, lifestyle zzso zzso pharmacological or surgical zzso zzso an zzso zzso has been proposed as an agent for an average weight loss of 4 zzso However, the development of anxiety and depressive symptoms can be major side zzso 

A 27-year-old zzso after using zzso (20 zzso for 1 month for weight loss, developed a major depressive episode with melancholic features, which zzso after the interruption of zzso 

To our knowledge, a major depressive episode with melancholic or zzso features zzso has not been described since the initiation of zzso pharmacological zzso The Hospital zzso and Depression zzso used in the zzso trials, zzso several key points of depressive zzso However, it zzso the zzso symptoms that zzso to the additional criterion for both of the mentioned features as well as suicidal zzso The severity of an episode could also be underestimated depending on the assessment tool or on the clinical zzso 

There may be an zzso of depressive melancholic and zzso side effects related to zzso use, due to the lack of consistent assessment with the appropriate screening zzso zzso strategies should be zzso for obesity treatment when there is a failure in the lifestyle and nutritional modification zzso Moreover, deeper global zzso changes should be made in the treatment and control of the global obesity zzso 

